| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.910 | 6.838 | 6.290 | 5.089 | 8.577 | 5.016 | 0 | 8.002 | 7.368 | 5.822 |
| Total Income - EUR | 5.910 | 6.838 | 6.290 | 5.089 | 8.577 | 5.016 | 0 | 9.964 | 7.368 | 5.822 |
| Total Expenses - EUR | 1.783 | 2.471 | 4.154 | 2.623 | 2.816 | 4.102 | 8.584 | 7.330 | 2.382 | 2.220 |
| Gross Profit/Loss - EUR | 4.128 | 4.367 | 2.136 | 2.465 | 5.761 | 914 | -8.584 | 2.634 | 4.986 | 3.602 |
| Net Profit/Loss - EUR | 3.950 | 4.162 | 1.947 | 2.313 | 5.503 | 771 | -8.584 | 2.394 | 4.188 | 3.037 |
| Employees | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Elicrivo S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 921 | 641 | 369 | 106 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 588 | 933 | 3.236 | 5.539 | 11.145 | 12.078 | 3.194 | 5.777 | 9.683 | 3.260 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 9.167 | 8.993 | 2.002 | 0 | 6.368 | 0 |
| Cash | 588 | 933 | 3.236 | 5.539 | 1.978 | 3.085 | 1.191 | 5.777 | 3.315 | 3.260 |
| Shareholders Funds | -2.490 | 1.697 | 3.615 | 5.861 | 11.251 | 11.809 | 2.963 | 5.366 | 9.538 | 3.085 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.078 | 158 | 262 | 46 | 0 | 269 | 231 | 411 | 145 | 175 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9602 - 9602" | |||||||||
| CAEN Financial Year |
9602
|
|||||||||
Comments - Elicrivo S.r.l.